Financhill
Back

Merck & Quote, Financials, Valuation and Earnings

Merck & Price Quote

$98.17
+0.12 (+-1.36%)
(Updated: December 21, 2024 at 5:37 AM ET)

Merck & Key Stats

Sell
25
Merck & (MRK) is a Sell

Day range:
$97.90 - $99.68
52-week range:
$94.48 - $134.63
Dividend yield:
3.18%
P/E ratio:
700.36
P/S ratio:
3.95
P/B ratio:
5.57%

Volume:
29.2M
Avg. volume:
13.5M
1-year change:
-6.94%
Market cap:
$248B
Revenue:
$60.1B
EPS:
$4.77

How Much Does Merck & Make?

Data Unavailable

Is Merck & Growing As A Company?

Data Unavailable

Merck & Stock Price Performance

  • Did Merck & Stock Go Up Last Month?
    Merck & share price went up by 0.63% last month
  • Did MRK's Share Price Rise Over The Last Year?
    MRK share price fell by -6.94% over the past 1 year

What Is Merck & 52-Week High & Low?

  • What Is Merck &’s 52-Week High Share Price?
    Merck & has traded as high as $134.63 over the past 52 weeks
  • What Is Merck &’s 52-Week Low Share Price?
    Merck & has traded as low as $94.48 over the past 52 weeks

Merck & Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Merck &?

Data Unavailable

Is Merck & Cash Flow Positive?

Data Unavailable

Merck & Return On Invested Capital

Data Unavailable

Merck & Earnings Date & Stock Price

  • What Is Merck &'s Stock Price Today?
    A single share of MRK can be purchased today for 98.05
  • What Is Merck &’s Stock Symbol?
    Merck & trades on the S&P500 under the ticker symbol: MRK
  • When Is Merck &’s Next Earnings Date?
    The next quarterly earnings date for Merck & is scheduled on February 4, 2025
  • When Is MRK's next ex-dividend date?
    Merck &'s next ex-dividend date is December 16, 2024
  • How To Buy Merck & Stock?
    You can buy Merck & shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Merck & Competitors

  • Who Are Merck &'s Competitors?
    Below is a list of companies who compete with Merck & or are related in some way:
    • Amgen Inc (AMGN)
    • Johnson & Johnson (JNJ)
    • Eli Lilly and Co (LLY)
    • Moderna Inc (MRNA)
    • Pfizer Inc (PFE)

Merck & Dividend Yield

Data Unavailable

Merck & Analyst Estimates

YoY Growth Past Surprise
EPS: -33.33% 0.03%
Revenue: 4.35% 0.87%

Analyst Recommendations

Buy Recommendations: 16
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 128.73
Upside from Last Price: 31.29%

Major Shareholders

Data Unavailable